Latest Operational Cash Flow News

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

ReNerve Limited delivered its strongest sales quarter ever with $211,000 in revenue, boosted by new distribution deals in Asia-Pacific and a $5 million funding facility to underpin growth.

De.mem Limited posted its second highest quarterly cash receipts of approximately $9.6 million for June 2026, marking 29 consecutive quarters of growth and positive operating cash flow of $424k. The company’s strong half-year performance is underpinned by recurring revenues, a robust Western Australian business, and record results from its German subsidiary.

GALE Pacific reported a robust $4.1 million operating cash inflow in Q4 FY26, culminating in $14.4 million for the full year. The company reduced borrowings by over $12 million, entering FY27 with a net cash position of $4.9 million and renewed focus on growth amid geopolitical uncertainties.

Appen's Q2 FY26 results highlight a robust 26% revenue increase, driven by a 75% jump in its China segment and improving global operations. The company reiterates its full-year guidance amid ongoing AI market growth and operational efficiencies.

Liontown Limited reported a record $137 million net cash flow in the June quarter, boosting its cash reserves to $561 million and hitting a new high in underground development metres. The company is on track to reach a 2.8 Mtpa mining run-rate by the end of FY27, supported by strong lithium prices and steady operational progress.

Mach7 Technologies delivered a positive operating cash flow in Q4 FY26, boosted its ARR run rate by 7.6% in constant currency, and secured multi-year subscription deals while expanding its partner ecosystem.

Stakk Ltd (ASX: SKK) has reported unaudited FY2026 revenue of A$14.68 million, beating prior guidance and delivering a 1,298% surge in customer cash receipts. The company also posted positive operating cash flow for the June quarter and anticipates further growth through its pending ParaScript acquisition.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Green360 Technologies has sealed its first binding supply contract with Holcim and ramped up MKX production, positioning itself as Australia’s leading supplier of low-carbon cement alternatives amid tightening SCM markets.

xReality Group delivered a robust Q4 FY26, with cash receipts up 46% to $6.9 million and net operating cash flow rising 64% to $2.2 million. The company completed a $5.6 million US Department of Defense project on time and secured its first European contract with the Swedish Armed Forces.

Horizon Oil achieved record production and sales in FY26, driven by its Thailand assets, and completed the off-market takeover of Cue Energy, expanding its footprint across five countries.